| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3497 |
| Trial ID | NCT05930314 |
| Disease | Systemic Lupus Erythematosus | Lupus Nephritis | Immune Thrombocytopenia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CNCT19|inaticabtagene autoleucel |
| Location approved | China |
| Phase | Early_Phase1 |
| Recruitment status | Enrolling By Invitation |
| Title | CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus |
| Year | 2023 |
| Country | China |
| Company sponsor | Peking Union Medical College Hospital |
| Other ID(s) | HY001009 |
| Cohort 1 | |||||||||||
|
|||||||||||